BioLife Solutions, Inc.
BLFS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | 10.4% | 6.2% | 799.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 66.9% | 64.6% | 65.9% | -241.6% |
| EBITDA | $0 | -$0 | $0 | $0 |
| % Margin | 9.1% | -56.4% | 0.7% | -197.1% |
| Net Income | $0 | -$0 | -$0 | $0 |
| % Margin | 2.2% | -62.3% | -1.9% | -363.9% |
| EPS Diluted | 0.01 | -0.33 | -0.01 | 0.26 |
| % Growth | 103% | -3,373.7% | -103.7% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |